Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents

NCT00697775 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: HBV-MPL vaccine Formulation A
BIOLOGICAL: HBV-MPL vaccine Formulation B
BIOLOGICAL: Engerix™-B

Sponsor

GlaxoSmithKline